Helicobacter cinaedi was first isolated from rectal cultures from homosexual men in 1984. In the 1980s to mid 1990s, the microorganism was mainly isolated from samples from homosexual men or immunocompromised patients; however, during the last two decades, H. cinaedi has been isolated from immunocompromised and from immunocompetent individuals worldwide. In Japan, the isolation of this microorganism was first reported in 2003. Since then, many cases have been reported in hospitals across the country. Despite many reports, the etiological properties and pathogenicity of H. cinaedi remain elusive; however, we are increasingly able to recognize some of the features and the clinical relevance of infection. In particular, a long incubation period is essential for detection in an automatic blood culture system and many of the recent isolates are resistant to both macrolides and quinolones. Furthermore, there is an association between infection and severe or chronic illnesses, such as meningitis or arteriosclerosis, in addition to mild diseases such as fever, abdominal pain, gastroenteritis, proctitis, diarrhea, erysipelas, cellulitis, arthritis, and bacteremia.
Introduction
The genus Helicobacter is a gram-negative spiral bacterium, belonging to the family Helicobacteriaceae of the order Campylobacterales within the class Epsilonproteobacteria.
Almost all members of genus Helicobacter show curved spiral (Sshape) or fusiform rods that are 0.2e1.2 Â 1.5e10 mm. Spiral cells may be tightly or loosely wound depending on the species and on the culture age and condition. Cells in old cultures or those exposed to air become coccoid. Periplasmic fibers may be observed on the cell surface in certain species (Fig. 1) .
Helicobacter cinaedi was first reported as a Campylobacter-like organism type-1 (CLO-1) in 1984 by Fennell et al. [1] They described three different types of CLOsdCLO-1, CLO-2 (later named "Campylobacter fennelliae"), and CLO-3 (still unnamed)dbased on biochemical traits (nitrate reduction and odor-producing ability) and membrane spot DNAeDNA hybridization results. The following year, Totten et al. [2] proposed the name "Campylobacter cinaedi" for CLO-1 organisms, although they demonstrated that there are two genetic groups within CLO-1 type, namely, CLO-1a and CLO-1b, with DNAeDNA hybridization values of 42e51%. Comparable values between CLO-2 and CLO-3 strains were far lower (less than 7%). These data and the lack of biochemical differences between CLO-1a and CLO-1b groups allowed the authors to include both within a single species. Thus, "C. cinaedi" is genetically diverse, involving at least two genomospecies. In 1991, "C. cinaedi" and also "C. fennelliae" were moved into the genus Helicobacter [3] as H. cinaedi and Helicobacter fennelliae [4] .
To date, the validation of 33 species in genus Helicobacter has been proposed, but only seven species have been isolated from human clinical specimens (Table 1, Fig. 2 ). Helicobacter pylori, classified as a "gastric-Helicobacter species" [5] , is the most well known species of the genus Helicobacter, although H. cinaedi, Helicobacter bilis, Helicobacter canadensis, Helicobacter canis, H. fennelliae, and Helicobacter pullorum, classed as "enterohepatic Helicobacter species" [5] , have also been isolated from human clinical specimens.
There is an invalid species name related to the genus Helicobacter known as "Flexispira rappini" (sometime referred as "Helicobacter rappini"). "F. rappini" was first proposed by Bryner et al. [6, 7] for a strain group of ultrastructurally distinct, ureaseproducing strains isolated from lambs, dogs, canine, ovine, and humans. Since this first study, strains have been identified as "F. rappini" by 16S rRNA gene sequence comparison, despite notable morphological and phenotypic differences [8e10] . In 2000, Dewhirst et al. [11] reported that "F. rappini" strains represent at least 10 Helicobacter taxa, and then H€ anninen et al. [12, 13] fell into each taxon as a valid Helicobacter species (Table 2) . Only taxon 7 (one strain isolated from dog stomach) and taxon 10 (three strains isolated from cotton-top tamarin) have not been clear their taxonomic positions. Indeed, the title of the 16S rRNA gene sequence information under the DDBJ/NCBI/EBI accession number M88138 (ATCC43879) is still 'Helicobacter sp. "Flexispira taxon 8" 16S ribosomal RNA gene'. This information may be a cause of misunderstanding and the researcher should carefully read both the title and the annotated text. Other provisional names, "Helicobacter westmeadii" [14] and "Helicobacter sp. strain Mainz," have been assigned to H. cinaedi [15] .
H. cinaedi was first isolated from rectal swabs obtained from homosexual men with proctitis, proctocolitis, and enteritis [1] , but the number of reports of H. cinaedi infection has been steadily growing throughout the last two decades. Because early reports mainly described the isolation of these microorganisms from homosexual men or immunocompromised patients, and their presence was attributed to human immunodeficiency virus infection, agammaglobulinemia, or some other underlying disease [16e21], the organisms were thought to be related to specific hosts. Recently, however, given that increasing numbers of infections have also been reported in immunocompetent patients [22e25], the patient group affected by H. cinaedi is larger than originally thought.
In Japan, the first report describing the isolation of H. cinaedi was published in 2003 [26] . Since then, isolation of this microorganism has been reported in patients regardless of gender and within a wide age range, from newborns to the elderly, by many a "Enterohepaic-Gastric" categories were basically according with Solnick et al. [5] . b Only seven species has been isolated from human specimen. Some reports described the detection of H. suis, H. felis, H. hepaticus, or H. ganmani using genetic methods but there is no report, to our knowledge, has isolated the organism. c Two isolation cases of H. trogontum from human clinical specimen have been reported on the Japanese Society for Clinical Microbiology Meeting (Journal report has not been yet).
Besides these species, "Candidatus Helicobacter bovis" (gastric helicobacter) has been proposed in 1999 [95] .
hospitals throughout the country. Matsumoto et al. [27] reported that the H. cinaedi positive rate in blood cultures was 0.06% (6/ 16,743 samples) of total blood samples and 0.22% (6/2718 samples) of blood samples with any positive culture, based on a prospective multicenter analysis in 13 hospitals over 6 months in Tokyo. This microorganism is not a clinically scarcity. Indeed, we have encountered many cases of H. cinaedi cellulitis and bacteremia that occurred continuously in both immunocompromised and immunocompetent subjects in hospitals. Now, we recognize that this microorganism should be considered a causative agent of nosocomial infection [24, 28, 29] . The association of this microorganism with a variety of human infections is receiving a growing amount of attention.
Diseases caused by H. cinaedi
H. cinaedi infection causes many kinds of symptoms including fever, abdominal pain, gastroenteritis, proctitis, diarrhea, erysipelas, cellulitis, arthritis, neonatal meningitis, and bacteremia [30] . Recently, a case of meningitis in a healthy adult and that of an axillobifemoral bypass graft infection in an immunocompetent patient were also reported [31, 32] .
Numerous reports have described bacteremia caused by H. cinaedi rather than by other Helicobacter species. This may be because this organism has a strong ability for vascular invasion resulting in bacterial translocation from the intestinal tract to the vascular system. Among the many cases of H. cinaedi bacteremia, the main symptom is fever. However, various symptoms are important to note. Fever is typically accompanied by arthritis and cellulitis at various sites in the body, which can be regarded either as the primary site of infection of bacteremia or a secondary focus of infection through the bacteremia.
In our experience, some patients had a sudden onset of local flat cellulitis (salmon-pink in color) accompanied by fever and an increase in C-reactive protein levels at various times after orthopedic surgery (range, 8e113 days; mean, 29 days) (Fig. 3) [24] . Cellulitis was often multifocal with no wound infection. Many of these patients had been treated for fracture and were immunocompetent.
Regarding a new disease relating to H. cinaedi infection, we recently found that H. cinaedi infection is involved in the progression of atherosclerosis. To investigate the relationship of H. cinaedi infection and atherosclerosis, we first analyzed H. cinaedi infection in the human atherosclerotic aorta by using immunohistochemistry with a specific anti-H. cinaedi antibody. Surprisingly, H. cinaedi antigen was clearly detected in atherosclerotic plaques in almost all postmortem human specimens [33] , where it was colocalized with macrophages. These observations strongly suggest that H. cinaedi may be closely associated with atherosclerosis in humans. We further investigated the effect of H. cinaedi infection on the development of atherosclerosis and its molecular mechanisms by using Apoe shl atherosclerosis model mice. Apoe shl mice orally infected with H. cinaedi for 8 weeks developed atherosclerosis in the aorta more extensively than uninfected control mice, as confirmed by lipid staining with Oil Red O for atherosclerosis plaques ( Fig. 4(A) ) [34] . To the best of our knowledge, this is first evidence of the involvement of H. cinaedi infection in the development of atherosclerosis.
The chronic inflammatory response is a widely accepted key mechanism in the progression of atherosclerosis [35, 36] . Gene expression analysis by real-time reverse transcription-PCR revealed significantly increased expression of inflammation-related genes, such as inducible nitric oxide synthase, interleukin-1, and Toll-like receptor 4, in aortic tissues of H. cinaedi-infected Apoe shl mice compared with those in uninfected control mice [34] . Mediators responsible for leukocyte adhesion and recruitment in the vascular wall, such as CeC motif chemokine 2 and intercellular adhesion molecule-1, were also upregulated in infected mice. Moreover, nested PCR analysis, which is a highly specific and sensitive detection method for H. cinaedi that we recently developed [37] , clearly showed that H. cinaedi DNA and RNA existed in the aorta of infected mice [34] . These findings suggested that oral infection by H. cinaedi might translocate to vascular tissue and induce chronic inflammation in the aorta, subsequently leading to atherosclerotic plaque formation. We further investigated the mechanism of atherosclerosis promotion by H. cinaedi infection by using in vitro experiments. The accumulation of lipids in macrophages, which is known as foam cell formation, is thought to be a critical step in the development of atherosclerosis. Thus, we examined the effect of H. cinaedi infection on foam cell formation in cultured macrophages derived from mouse and human [34] . Twenty-four hours after H. cinaedi was added to the culture medium, macrophages had markedly accumulated lipid droplets, which is the hallmark of foam cell formation ( Fig. 4(B) ). Uninfected cells and H. pylori-infected cells did not show such accumulation of lipid droplets, suggesting that H. cinaedi specifically induced foam cell formation. Further examination of the mechanism of foam cell formation induced by H. cinaedi infection revealed that a change in the metabolism of cholesterol induced by infection may be involved. Specifically, H. cinaedi infection of macrophages increased the expression of LDL receptor, known to be involved in cholesterol intake, in macrophages. Also, H. cinaedi infection of macrophages decreased the expression of the ATP-binding cassette transporter G1 (ABCG1), which is thought to be involved in the excretion of cholesterol to outside of the macrophages. Although the detailed molecular mechanisms of the changes in expression of the LDL receptor and ABCG1 during H. cinaedi infection remain unclear, these changes would affect intracellular cholesterol metabolism and cause an accumulation of cholesterol. These results suggest that H. cinaedi infection promotes the development of atherosclerosis through chronic vascular inflammation, macrophage activation, and subsequent foam cell formation (Fig. 5) .
Some reports have suggested that infection by specific microbes may be involved in the pathogenesis of atherosclerosis. These microbes include various pathogens, such as Chlamydia pneumoniae and Porphyromonas gingivalis [38, 39] . However, the exact mechanisms involved in the promotion of atherosclerosis and to what extent they are related to human atherosclerosis is not fully understood. Our recent findings presented above showed a new mechanism of atherosclerosis development promoted by bacterial infection. These may be related to the vascular tropism of H. cinaedi and frequent recurrences. Further investigation is needed to clarify the involvement of H. cinaedi infection in human atherosclerosis and the detailed molecular mechanisms involved in H. cinaedi promotion of foam cell formation in macrophages. Additional investigations to determine the etiological role of H. cinaedi in the development of atherosclerotic cardiovascular diseases are also warranted.
Virulence factors
Only two virulence factors have been reported in the literature: cytolethal distending toxin (Cdt) and alkyl hydroperoxide reductase (AhpC). Cdt is a lethal toxin to eukaryotic cells as a result of apoptosis induction and cell cycle arrest in host eukaryotic cells [40, 41] . AhpC is an enzyme that converts various alkyl hydroperoxides to their corresponding alcohols, and can change hydrogen peroxide to water. This enzyme contributes to microorganism survival in host conditions via the protection of the cells from oxidative stress [42] .
During our investigation to determine the complete genome sequence of a human clinical isolate (PAGU 611) from the blood sample of a cellulitis subject, we revealed that the microorganism holds a Type VI secretion system (T6SS) which is thought to be related to its virulence [43] . T6SS is a kind of complex multicomponent secretion machine, often called a "needle" or "molecular syringe". In many cases, T6SS delivers bacteriolytic effectors to target cells, such as other bacteria or eukaryotic hosts, and in some cases is involved in symbiotic interactions with eukaryotic hosts [44, 45] .
In the case of Helicobacter hepaticus, another enterohepatic species that is harbored in mouse intestines, T6SS was reported to play an important role in persistent colonization to promote a balanced relationship with the host via the T6SS directed antiinflammatory gene expression profiles in intestinal epithelial cells and CD4 þ T cells [46] . Another report described an association between VgrG1, a secreted protein of T6SS, and bacterial colitogenic potential [47] . The role of the T6SS in H. cinaedi infection is not clear; however, there might be a similar virulence function. The PAGU 611 chromosome encodes two known virulence factors, described above, cdt and ahpC genes, and also several putative virulence-related proteins, such as fibronectin-and fibrinogenbinding proteins, neutrophil activation protein, and Campylobacter jejuni invasion antigen B [43] . The type strain of H. cinaedi, another complete genome determined strain [48] , has all of the abovementioned (putative) virulence factors; thus, these factors might be commonly harbored within the human isolates.
Further investigation is needed to clarify the virulence of this microorganism.
Clinical laboratory tests
It is well known that H. cinaedi is a fastidious and slow-growing organism and that detection and cultivation are extremely difficult. In this section, methods of detection, culture, and identification are described, as well as the description of new taxon for the genus Helicobacter.
Detection on blood culture system
Isolates of H. cinaedi are mainly obtained from blood and, to a lesser extent, fecal samples. In fact, H. cinaedi is in many cases first detected from blood culture using an automatic blood culture system. Nowadays, many hospital laboratories employ an automatic blood culture system, such as the BACTEC or BacT/ALERT systems. Recently, another blood culture system, VersaTREK, has been introduced in Japan.
Because H. cinaedi are slow-growing organisms, a relatively prolonged incubation time is generally required. In many reports, and in our experience, 4e10 days are needed for a positive result in the culture bottle of an automatic blood culture system, such as the BACTEC system using an aerobic bottle. Therefore, once the culture test is finished within 3e4 days, the possibility of detection can become critically low due to not reaching the detection limit. Detection reports of H. cinaedi using the BacT/ALERT system are very limited. In the case of the BacT/ALERT system, H. cinaedi has been detected using both aerobic and anaerobic bottles [22, 49, 50] . In our experience, the VersaTREK system is superior for the detection of this microorganism. Because the VersaTREK system provides excellent growth ability and is highly sensitive, H. cinaedi isolates can be detected very quickly. Some clinical laboratory technologists have reported being able to detect H. cinaedi within 3 days [51] . In our preliminary experiment using five H. cinaedi isolates, the VersaTREK system detected all isolates within 3 days, whereas other systems needed more incubation time or detection failed [52] .
Culture
H. cinaedi isolates essentially required microaerobic conditions (5e10% O 2 ) and high humidity. Blood agar plates stored in a refrigerator for a few days often do not support the growth of H. cinaedi because the water content may be reduced; therefore, the use of fresh medium is strongly recommended. It is well known that the growth of H. cinaedi is accelerated by adding hydrogen gas (5e10%) to the microaerobic conditions. It is preferable to use such gas conditions (e.g. 6% O 2 , 7% H 2 , 7% CO 2 , and 80% N 2 ) in the initial culture step of the clinical specimen or in the culture bottle to increase the culture success rate. Unfortunately, many commercially available microaerobic gas generating packs, such as the Gas-Pak system, can deoxidize and generate CO 2 but not supply hydrogen gas; therefore, H. cinaedi growth sometimes fails or is insufficient. H. cinaedi cultured on an agar plate may appear as a swarming thin film, which is difficult to identify visually. Therefore, the culture should be carefully checked on the plate. Many selective media are suitable for the isolation of H. cinaedi. Baba et al. [53] reported that many different selective media for Campylobacter or Helicobacter, such as Skirrow and Butzler Blaser, can be used, with the exception of CCDA (charcoal-cefazolin-sodium deoxycholate agar), which failed to grow the H. cinaedi isolates [54, 55] .
Tomida et al. [56] reported that "Helicobacter medium" (Nissui Pharm. Co. Ltd) is excellent, because it has good potential for supporting the growth of H. cinaedi isolates. Furthermore, because the medium contains a serum (not erythrocytes) and reductionreactive dyes, the growing bacteria are easy to observe, even in film form, due to their purple color against the translucent medium.
These selective media would be useful for isolating H. cinaedi from specimens such as feces or environmental samples. Another approach using filtration method is described in "Cape Town Campylobacter and Helicobacter Protocol", a document issued by the South Central Association for Clinical Microbiology, a not-forprofit organization (http://www.scacm.org/index.htm).
Identification
The biochemical identification of this organism is problematic due to unstable phenotypic reactions. For example, results of the 42 C (Celsius temperature) growth test led to disagreement between researchers; Lawson [30] described a negative result but Kiehlbauch et al. [57] reported a positive result. The results of the alkaline-phosphatase test are difficult to read because the gradual color changes are dependent on the incubation time and certain strains give only the faintest hint of color [58] .
Due to these unstable phenotypic reactions and a lack of substantial data sets, commercially available identification kits do not produce reliable results. Therefore, identification has been based on nucleotide sequence or species-specific polymerase chain reaction (PCR). We have developed a nested PCR system with high specificity and sensitivity (c.a. 10 2 CFU/ml) for detecting H. cinaedi based on the sequence of the known virulence factor gene, cdtB [37] . By using this cdtB gene-based PCR detection system, we identified more than 200 isolates received from various hospitals across the country. Another advantage of using PCR techniques is that culture is unnecessary. Since the culture of H. cinaedi isolates is very difficult and sometimes, as mentioned above, cells fail to even grow, the present DNA detection test is convenient, as it can be directly performed even in these cases from the contents of a culture bottle using PCR. Analysis of 16S rRNA gene sequences is one of the most common approaches for investigating the phylogenetic positions of bacterial strains; however, Vandamme et al. [59] reported a problem due to misidentification of H. cinaedi using 16S rRNA gene sequences. The isolate believed to be H. cinaedi was located some distance from the phylogenetic cluster of the type strain, it is required careful consideration. Yet almost all isolates that we found were located within or very close to the type strain's cluster, and were correctly identified using 16S rRNA gene phylogenetic analysis. As described above, the species H. cinaedi includes at least two genetically diverse microorganisms, and Vandamme et al. [59] used certain strains such as the previously named "Helicobacter sp. strain Mainz", or certain canine isolates; therefore, the antecedents of the strains should be clarified.
Kuhnert and Burnens [60] highlight another potential source of error in the identification of H. cinaedi. ATCC 35863 was designated and distributed as a type strain of H. cinaedi but is actually H. fennelliae. Identification operations involve matching data sets obtained from unknown isolates with those of previously described taxa, so any mislabeling of the latter can result in unknown isolates being misidentified [60] . Fortunately, this problem has already been fixed (ATCC 35863 is now labeled as H. fennelliae).
PCR-DGGE (denature gradient gel electrophoresis) method using amplified 16S rRNA gene for the identification of Helicobacter species has also been reported [61] . Other gene sequences, such as RNA polymerase-b subunit (rpoB) and b 0 -subunits (rpoC) genes [62] , DNA gyrase protein B-subunit (gyrB) gene [63] , 60 kDa heat shock protein gene (hsp60) [64] , 23S rRNA gene [65] , and urease protein B-subunit (ureB) gene [13] have also been used in phylogenetic studies of the genus Helicobacter. These analysis methods are certainly thought to be useful, but each method has particular strengths and limitations relating to the accumulation of sequence data and the distinguishing powers. Therefore, researchers must carefully consider the advantages and disadvantages of each analysis method.
Description of a new taxon within the genus helicobacter
"Recommended minimal standards for describing new species of the genus Helicobacter" was published in 2000 by the International Committee of Systematic Bacteriology subcommittee on the taxonomy of Campylobacter and related bacteria [66, 67] . The recommendation stated that at least five strains should be used and both phenotypic and molecular data collected. Some basic biochemical testing procedures and the medium formulas for Helicobacter and Campylobacter are described by On and Holmes [58, 68, 69] . The molecular data described in the recommendation includes DNA G þ Cmol%, almost full-length 16S rRNA gene sequences (more than 1450 bp) including intervening sequences (if any), DNAeDNA hybridization data, and others. To propose a new species or subspecies, researchers should include these data.
Antimicrobial susceptibility testing
There are no recommended guidelines for susceptibility testing and the treatment of diagnosed infections with H. cinaedi.
In 1991, one report clearly stated that H. cinaedi failed to grow during testing for antimicrobial susceptibility by a broth microdilution method [70] . Antimicrobial susceptibility testing for H. cinaedi isolates has been carried out using the agar dilution method [18, 50, 57] , which is too cumbersome to carry out routinely in hospital laboratories. The E-test is an alternative method used to measure antimicrobial susceptibility [25, 71] ; however, because H. cinaedi has a migratory growth pattern, the E-test may be inaccurate due to unclear edges around the growth inhibition zone.
Comparative analysis of the growth ability of H. cinaedi isolates in some broth media revealed that modified Levinthal broth is suitable for supporting the growth of H. cinaedi strains in 96-well format microplates [72] . Minimum inhibitory concentration (MIC) values obtained from the broth microdilution method using the modified Levinthal broth are almost same as those obtained from the traditional agar dilution method. From these data, Tomida et al. [72] concluded that a broth microdilution method for antimicrobial susceptibility testing of H. cinaedi, which can be performed easily, is a reliable method for determining the MIC.
H. cinaedi strains generally show low MIC values for carbapenems, aminoglycosides, and tetracycline (MIC 90 &1 mg/ml for imipenem, gentamicin, and tetracycline [75] . MIC values of recent isolates from several hospitals in Japan are summarized in Table 3 .
It is well known that efflux pumps contribute to antimicrobial resistance in many cases. The resistance nodulation cell division (RND) type multidrug efflux transporters are the clinically relevant chromosomally encoded fundamental antimicrobial resistance mechanisms in Gram-negative bacteria [76] . We identified two genes (locus-tags HCN_0595 and HCN_1563) in the chromosome of H. cinaedi PAGU 611 encoding the hydrophobe/amphiphile efflux-1 sub-family of the RND family [43, 77] . The genes were also conserved in other H. cinaedi genomic strains of CCUG 18818 and ATCC BAA-847 [48] . HCN_0595 orthologs are found in various species among the genus Helicobacter (e.g. H. pylori 26695 and H. hepaticus ATCC 51449), while HCN_1563 orthologs are found only in enterohepatic Helicobacter species (e.g. H. hepaticus ATCC 51449) examined. A phylogenetic tree was constructed using COBALT software (Fig. 6) [78] . HCN_1563 pump is between CmeB of C. jejuni and BepE pump of Brucella suis, both of which are major antimicrobial resistance contributors, while HCN_0595 pump is between HefC of H. pylori and CmeF of C. jejuni, both of which are likely to be small or secondary contributors. The CmeABC pump contributes to the acquired resistance of C. jejuni to macrolides and fluoroquinolones [79, 80] ; HCN_1563 pump of H. cinaedi may be associated with resistance to these drugs. Another eight putative drug transporter genes (one belonging to the major facilitator family, one to the ATPbinding cassette family, two to the multidrug and toxin extrusion family, and four to the small multidrug resistance family) are found in the genome of H. cinaedi PAGU 611. The orthologs are also encoded in H. cinaedi ATCC BAA-847 and H. hepaticus ATCC 51449 [77] . It is not clear how the gene products operate and how they contribute to antimicrobial resistance, and further investigation is needed. The data were basically collected by the broth microdilition method [72] . MIC values reported by Rimbra et al. [75] using agar dilution method are described in the parentheses.
a Meropenem also showed low MIC values (&0.12 mg/ml) in our small scale examination (n ¼ 4).
b MIC value of minocycline in our small scale examination also showed &0.12 mg/ ml (n ¼ 4).
Chemotherapy and recurrence
Various antibiotic agents alone or in combination have been successfully used for treating infections caused by H. cinaedi [18, 21, 24, 29, 74] . Symptoms caused by this microorganism, such as fever or cellulitis, resolve after 2 or 3 days of drug therapy. In some cases the symptoms disappear spontaneously and the patients becomes asymptomatic, although the microorganisms are still present in the patients and will recur [81] . The prognosis is generally good, but it should be recognized that about 30e60% of patients have recurrent symptoms [24, 26, 74, 82, 83] . The CDC recommends long-term therapy of about 2e6 weeks, rather than short-term therapy of up to 10 days [74] . Many other reports also describe long-term chemotherapy for the prevention of recurrent symptoms [22, 74, 81] .
No recommended guidelines are available for the treatment of a diagnosed infection of H. cinaedi. As an alternative guide to chemotherapy, it may be noted that in testing for H. cinaedi in recurrent-bacteremia cases, the approach used is an interpretation of the susceptibility to clarithromycin based on the CLSI (Clinical and Laboratory Standards Institute; http://clsi.org/) guidelines for H. pylori and on published reports for metronidazole and amoxicillin [84, 85] . For other antibiotics, interpretation is based on CLSI guidelines for gram-negative bacilli [81] . Although such a challenging report exists, authorized guidelines for the treatment of H. cinaedi infections, including the clinical breakpoints of antimicrobial agents, have not been established.
Epidemiological analysis
The infection route of H. cinaedi has not been clarified. However, H. cinaedi has been found in a wide range of animals, from domestic pets to wild animals, including cats, dogs, hamsters, rats, foxes, and rhesus monkeys [5,86e88] .
Many reports have raised a suspicion of zoonotic transmission from animals to humans [89, 90] . Orlicek et al. [47] reported that H. cinaedi was responsible for bacteremia and meningitis in a newborn whose mother cared for a pet hamster during her pregnancy. Lasry et al. [22] reported H. cinaedi-related septic arthritis and bacteremia in an immunocompetent patient who worked occasionally as a shepherd and had contact with cows and farm animals. Indeed, H. cinaedi is reported to be a member of the normal intestinal flora in hamsters [91] . Another report [92] describes certain enterohepatic Helicobacter species, including H. cinaedi, are located mainly in sites in the lower intestinal tract such as the cecum and colon in dogs, rather than in the upper parts such as the as duodenum, jejunum, or ileum. It is likely that contact infection has occurred from animal to human. However, there are no reports of the simultaneous isolation of H. cinaedi in human patients and close contact animals. It is noteworthy that H. cinaedi isolates from human, dog, and hamster formed distinct ribotype pattern groups according to their host source [57] . This kind of discrepancy between human and animal isolates has been recently recognized by using the matrix-assisted laser desorption/ionization time of flight mass spectrometry system [93] .
Epidemiological analysis methods such as plasmid profiles, pulse-field gel electrophoresis, randomly amplified polymorphic DNA, and multilocus sequence typing have been proposed for H. cinaedi isolates [24, 28, 57] .
We have developed a nested PCR system, as mentioned above [37] , to directly catch the bacterial DNA (antigen detecting system) in the clinical specimens, and have established an immunological diagnosis method (antibody detecting test) with high specificity to detect the exposure history of H. cinaedi [94] . Using these methods, we have analyzed many healthy subjects working in a hospital (doctors, nurses, staff members, etc.) and found some healthy individuals infected with H. cinaedi [37] . This finding suggests asymptomatic carriers exist, and may be related to nosocomial infections.
Further investigations are needed to clarify the complete infection route and the nosocomial transmission route of H. cinaedi infection.
Conclusion
It appears that, because H. cinaedi is thought not to cause acute severe disease, little importance has been placed on this organism. However, we now know that it likely causes nosocomial infections, is difficult to eradicate, and has a high incidence of recurrence. Furthermore, an association with chronic illnesses such as arrhythmia and arteriosclerosis has been pointed out in recent years.
Therefore, there is a need to rapidly establish guidelines for the use of antimicrobial agents, susceptibility testing, and the treatment regimen in diagnosed H. cinaedi infection cases. In addition, it is important to elucidate the infection route. To our knowledge, no medical center or clinic that has detected recurrent H. cinaedi infection has successfully eradicated it. Taking into account the variety of environmental or animal vector routes, both the route and the mechanism of infection by this microorganism should be clarified. Furthermore, we need to carefully monitor and understand the trends in H. cinaedi infections.
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